期刊
EMERGING INFECTIOUS DISEASES
卷 8, 期 12, 页码 1392-1397出版社
CENTER DISEASE CONTROL
DOI: 10.3201/eid0812.020229
关键词
-
资金
- NIAID NIH HHS [AI-10984, R01 AI050175, AI-50175] Funding Source: Medline
- ODCDC CDC HHS [U50/CCU620541] Funding Source: Medline
Results of experiments evaluating the efficacy of three immunization strategies for the prevention of West Nile virus (WNV) encephalitis are reported. Immunization strategies evaluated included a killed virus veterinary vaccine, a live attenuated chimeric virus vaccine candidate, and passive immunization with WNV-immune serum; all were tested by using a hamster model of the disease. Each product protected the animals from clinical illness and death when challenged with a hamster-virulent wild-type WNV strain 1 month after initial immunization. The live attenuated chimeric virus vaccine candidate induced the highest humoral antibody responses, as measured by hemagglutination inhibition, complement fixation, and plaque reduction neutralization tests. Although the duration of protective immunity was not determined in this study, our preliminary results and the cumulative experience of other virus vaccines suggest that the live attenuated chimeric virus provides the longest lasting immunity.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据